{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T16:40:31Z","timestamp":1738514431350,"version":"3.35.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ejphar.2008.10.060","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T09:02:38Z","timestamp":1226307758000},"page":"112-116","source":"Crossref","is-referenced-by-count":12,"title":["Intravenously administered phosphodiesterase 4 inhibitors dilate retinal blood vessels in rats"],"prefix":"10.1016","volume":"602","author":[{"given":"Tomoyo","family":"Miwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.10.060_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1152\/physrev.1975.55.3.383","article-title":"Blood circulation and fluid dynamics in the eye","volume":"55","author":"Bill","year":"1975","journal-title":"Physiol. Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2008.10.060_bib2","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00005344-198500073-00011","article-title":"Control of ocular blood flow","volume":"7","author":"Bill","year":"1985","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1364\/AO.20.002097","article-title":"Model for laser Doppler measurements of blood flow in tissue","volume":"20","author":"Bonner","year":"1981","journal-title":"Appl. Opt."},{"key":"10.1016\/j.ejphar.2008.10.060_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2008.10.060_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dmrr.432","article-title":"Pharmacological approach to diabetic retinopathy","volume":"20","author":"De La Cruz","year":"2004","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"10.1016\/j.ejphar.2008.10.060_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000055622","article-title":"Regulatory mechanisms in the retinal and choroidal circulation","volume":"32","author":"Delaey","year":"2000","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejphar.2008.10.060_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2008.10.060_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.icu.0000156134.38495.0b","article-title":"Blood flow in glaucoma","volume":"16","author":"Grieshaber","year":"2005","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.RES.83.7.721","article-title":"A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet","volume":"83","author":"Hardy","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.10.060_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archopht.116.11.1491","article-title":"Regulation of retinal and optic nerve blood flow","volume":"116","author":"Harris","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-3565(25)24776-0","article-title":"Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog","volume":"257","author":"Heaslip","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.10.060_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(98)00015-6","article-title":"Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats","volume":"344","author":"Hotta","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.1991.tb12457.x","article-title":"Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors","volume":"104","author":"Komas","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1748-1716.1991.tb09130.x","article-title":"Effects of selective phosphodiesterase inhibitors on isolated coronary, lung, and renal arteries from man and rat","volume":"142","author":"Lindgren","year":"1991","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2008.10.060_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1748-1716.1990.tb08993.x","article-title":"Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels","volume":"140","author":"Lindgren","year":"1990","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2008.10.060_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1254\/jphs.FP0061061","article-title":"Intravenously administered vasodilatory prostaglandins increase retinal and choroidal blood flow in rats","volume":"103","author":"Mori","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.10.060_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2007.05.052","article-title":"Stimulation of prostanoid IP and EP2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats","volume":"570","author":"Mori","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vph.2006.09.002","article-title":"Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats","volume":"46","author":"Nakazawa","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00210-007-0165-7","article-title":"Vasodilator effect of nicorandil on retinal blood vessels in rats","volume":"375","author":"Ogawa","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/mol.58.2.247","article-title":"Dual expression and differential regulation of phosphodiesterase 3B and phosphodiesterase 3A in human vascular smooth muscle: Implications for phosphodiesterase 3 inhibition in human cardiovascular tissues","volume":"58","author":"Palmer","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1469-7580.2005.00395.x","article-title":"Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures","volume":"206","author":"Patton","year":"2005","journal-title":"J. Anat."},{"key":"10.1016\/j.ejphar.2008.10.060_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s001250051171","article-title":"Ocular blood flow and associated functional deviations in diabetic retinopathy","volume":"42","author":"Schmetterer","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2008.10.060_bib23","first-page":"3084","article-title":"Optic nerve and peripapillary choroidal microvasculature of the rat eye","volume":"40","author":"Sugiyama","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2008.10.060_bib24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cellsig.2007.03.012","article-title":"Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice","volume":"19","author":"Sun","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2008.10.060_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00345-005-0026-2","article-title":"Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries- immnohistochemical distribution and functional significance","volume":"23","author":"Waldkirch","year":"2005","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2008.10.060_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004647-199702000-00011","article-title":"Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors","volume":"17","author":"Willette","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908011412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908011412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T16:12:51Z","timestamp":1738512771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908011412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0014299908011412"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.10.060","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}